Fatty Liver Disease
Research on metabolic dysfunction-associated steatotic liver disease (MASLD), formerly NAFLD/NASH. Includes hepatic steatosis, inflammation, fibrosis, and their treatment.
Quick Answer
What it is
Research on metabolic dysfunction-associated steatotic liver disease (MASLD), formerly NAFLD/NASH. Includes hepatic steatosis, inflammation, fibrosis, and their treatment.
Key findings
- Grade A: Liver Fat Reduction (Retatrutide (GLP-3 Triple Agonist))
Safety
No specific caution or interaction language was detected in the current summary/outcome notes.
ℹ️ Quick Facts
Quick Facts: Fatty Liver Disease
- Supplements Studied:1
Detailed Outcomes
Research Citations (61)
Related Conditions
Type 2 Diabetes
1 shared supplement · 868 outcomes
Type 2 diabetes (T2D) is a disease in which blood glucose levels are too high. It is characterized by insulin resistance in muscle, fat, and pancreas cells and an inability of the pancreas to manufacture enough insulin to control blood glucose levels. T2D is strongly associated with excess body fat, and weight loss induced by lifestyle changes is extremely effective for treating T2D.
Osteoarthritis (OA)
1 shared supplement · 116 outcomes
Osteoarthritis (OA) is a joint disease involving cartilage degradation. It’s not clear what exactly causes OA, but some risk factors include joint injury, overweight or obesity, aging, misaligned joints, and family history. Lots of supplements have been studied in people with OA, as have lifestyle interventions including weight loss and exercise.
Obesity
1 shared supplement · 525 outcomes
Obesity is a condition of excessive body fat that increases the risk for other conditions such as diabetes and heart disease. Fat is how the body stores extra calories that were eaten but not used. Obesity treatment usually involves restricting the calories eaten or creating a negative calorie balance.